Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

mAChR antagonists/beta2-adrenoceptor agonists patented by Beijing Showby Pharmaceutical

July 9, 2018

Galapagos reports topline results for GLPG-2737, updates triple combination plans in cystic fibrosis

June 29, 2018

Vertex patents CFTR modulators

June 28, 2018

aTyr Pharma presents positive phase I results for ATYR-1923

June 27, 2018

Synairgen reports interim data from phase II trial of SNG-001 in COPD

June 22, 2018

Faron Pharmaceuticals presents biomarker analysis of the phase III INTEREST trial

June 15, 2018

First-in-human data on FDL-176 in healthy subjects presented

June 12, 2018

Researchers unveil TMEM16A as potential therapeutic target for cystic fibrosis

June 8, 2018

Positive results presented from ongoing phase I trial of PTI-801 in patients with CF

June 7, 2018

New RORC modulators divulged by Bristol-Myers Squibb

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...